Literature DB >> 19826948

Impaired synthesis of erythropoietin, glutamine synthetase and metallothionein in the skin of NOD/SCID/gamma(c)(null) and Foxn1 nu/nu mice with misbalanced production of MHC class II complex.

L Danielyan1, S Verleysdonk, M Buadze, C H Gleiter, G H Buniatian.   

Abstract

Most skin pathologies are characterized by unbalanced synthesis of major histocompatability complex II (MHC-II) proteins. Healthy skin keratinocytes simultaneously produce large amounts of MHC-II and regeneration-supporting proteins, e.g. erythropoietin (EPO), EPO receptor (EPOR), glutamine synthetase (GS) and metallothionein (MT). To investigate the level of regeneration-supporting proteins in the skin during misbalanced production of MHC-II, skin sections from nonobese diabetic/severe combined immunodeficient (NOD/SCID)/gamma (c) (null) and or Foxn1 nu/nu mice which are a priory known to under- and over-express MHC II, respectively, were used. Double immunofluorescence analysis of NOD/SCID/gamma (c) (null) skin sections showed striking decrease in expression of MHC-II, EPO, GS and MT. In Foxn1 nu/nu mouse skin, GS was strongly expressed in epidermis and in hair follicles (HF), which lacked EPO. In nude mouse skin EPO and MHC-II were over-expressed in dermal fibroblasts and they were completely absent from cortex, channel, medulla and keratinocytes surrounding the HF, suggest a role for EPO in health and pathology of hair follicle. The level of expression of EPO and GS in both mutant mice was confirmed by results of Western blot analyses. Strong immunoresponsiveness of EPOR in the hair channels of NOD/SCID/gamma (c) (null) mouse skin suggests increased requirements of skin cells for EPO and possible benefits of exogenous EPO application during disorders of immune system accompanied by loss MHC-II in skin cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19826948     DOI: 10.1007/s11064-009-0074-x

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  91 in total

1.  Overexpression of metallothionein-II sensitizes rodent cells to apoptosis induced by DNA cross-linking agent through inhibition of NF-kappa B activation.

Authors:  Efterpi Papouli; Martine Defais; Florence Larminat
Journal:  J Biol Chem       Date:  2001-11-16       Impact factor: 5.157

2.  Antigen presentation by keratinocytes directs autoimmune skin disease.

Authors:  Lian Fan; Brian W Busser; Traci Q Lifsted; Mohamed Oukka; David Lo; Terri M Laufer
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

3.  Erythropoietin and erythropoietin receptor expression after experimental spinal cord injury encourages therapy by exogenous erythropoietin.

Authors:  Giovanni Grasso; Alessandra Sfacteria; Marcello Passalacqua; Antonio Morabito; Michele Buemi; Battesimo Macrì; Michael L Brines; Francesco Tomasello
Journal:  Neurosurgery       Date:  2005-04       Impact factor: 4.654

4.  Human keratinocytes respond to interleukin-18: implication for the course of chronic inflammatory skin diseases.

Authors:  Miriam Wittmann; Rahul Purwar; Christina Hartmann; Ralf Gutzmer; Thomas Werfel
Journal:  J Invest Dermatol       Date:  2005-06       Impact factor: 8.551

5.  Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis.

Authors:  Costanza Savino; Rosetta Pedotti; Fulvio Baggi; Federica Ubiali; Barbara Gallo; Sara Nava; Paolo Bigini; Sara Barbera; Elena Fumagalli; Tiziana Mennini; Annamaria Vezzani; Massimo Rizzi; Thomas Coleman; Anthony Cerami; Michael Brines; Pietro Ghezzi; Roberto Bianchi
Journal:  J Neuroimmunol       Date:  2005-12-07       Impact factor: 3.478

6.  Glutamine synthetase from pig brain: binding of adenosine triphosphate.

Authors:  L Jaenicke; W Berson
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1977-07

7.  The receptor for erythropoietin is present on cutaneous mast cells.

Authors:  Rieko Isogai; Masae Takahashi; Kinuyo Aisu; Yoshitaka Horiuti; Yoshinori Aragane; Akira Kawada; Tadashi Tezuka
Journal:  Arch Dermatol Res       Date:  2006-01-19       Impact factor: 3.017

8.  Erythropoietin-induced metallothionein gene expression: role in proliferation of K562 cells.

Authors:  Asim B Abdel-Mageed; Fusheng Zhao; Barbara J Rider; Krishna C Agrawal
Journal:  Exp Biol Med (Maywood)       Date:  2003-10

9.  Enhanced erythropoietin heterogeneity in a CHO culture is caused by proteolytic degradation and can be eliminated by a high glutamine level.

Authors:  M Yang; M Butler
Journal:  Cytotechnology       Date:  2000-10       Impact factor: 2.058

10.  Erythropoietin increases platelet reactivity and platelet counts in patients with alcoholic liver cirrhosis: a randomized, double-blind, placebo-controlled study.

Authors:  M Homoncik; P Jilma-Stohlawetz; M Schmid; A Ferlitsch; M Peck-Radosavljevic
Journal:  Aliment Pharmacol Ther       Date:  2004-08-15       Impact factor: 8.171

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.